Christopher Dittus, DO, MPH, will provide an overview of how to diagnose Waldenstrom Macroglobulinemia (WM) and differentiate it from MGUS and other types of indolent lymphoma. he will discuss potential emergency situations related to hyperviscosity and how to effectively manage this complication. Regarding treatment, Dr. Dittus will discuss standard frontline and relapsed therapy and will review clinical trials evaluating immunotherapy and novel targeted agents.
Learning Objectives
Identify Waldenstrom Macroglobulinemia.
Explain standard treatment approaches for Waldenstrom Macroglobulinemia.
Discuss novel targeted and immunotherapy treatments for Waldenstrom Macroglobulinemia.
You must have an account and be logged in to register. Please contact us with any questions at [email protected] or (919) 445–1000.
Disclaimer
The views expressed herein are those of the presenter, they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill.
Cancer Treatment in North Carolina: Research to Practice (formerly Medical and Surgical Oncology) webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included.
This series incorporates an understanding of practice dynamics and concerns throughout the state of North Carolina, and the availability of clinical trials and subspecialty expertise to inform care.
These webinars provide FREE continuing education credit.
Christopher Dittus, DO, MPH
Associate Professor of Medicine Division of Hematology UNC Lineberger Comprehensive Cancer Center UNC School of Medicine University of North Carolina at Chapel Hill
Disclosures
Activity Directors This activity has been planned and implemented under the sole supervision of the Course Director, Stephanie Wheeler, PhD, MPH, and Emily Ray, MD, of the UNC School of Medicine in association with the UNC Office of Continuing Professional Development (CPD). Dr. Wheeler received research support from AstraZeneca (ended June 2023) and Pfizer Medical Foundation (ended December 2023). These financial relationships have been mitigated. Dr. Emily Ray has no relevant financial relationships with ineligible companies as defined by the ACCME. CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME. The planning committee members and their relevant financial relationships with ineligible companies as defined by the ACCME can be found at https://learn.unclcn.org/content/unclcn-webinar-planning-committee.
ANCC Except as defined above, no one with the ability to control content of this activity has a relevant financial relationship with an ineligible company.
Accreditation Statements
The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency. No partial credit will be provided.
1.25 NCPD/CNE UNC Health is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Criteria for successful completion to claim CE Certificate requires attendance at the NCPD activity, and submission of an evaluation within 7 days.
1.00 ACPE Pharmacist The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
The Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 1.0 ACPE Credit(s).
1.00 ACPE Pharmacy Tech The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
The Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 1.0 ACPE Credit(s).
1.00 ODS/CTR Approved by the National Cancer Registrars Association (NCRA).
This activity is worth 1 credit hour and is approved by the NCRA.
1.50 ASRT Approved by the American Society of Radiologic Technologists (ASRT).
This activity is worth 1 credit hour and is approved by the ASRT.
Notice
In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to view a minimum of 53 minutes of the live webinar video to receive CE credit. Please contact your individual accreditation agencies for more details.
Altering or submitting modified certificates constitutes fraud that can result in punitive action by the accrediting agency.
Facebook
X
LinkedIn
Forward
